New users of antidepressant medications: first episode duration and predictors of discontinuation
- 430 Downloads
Clinical guidelines recommend that antidepressant treatment should be continued for at least 6 months. We examined persistence in patients initiated on an antidepressant medication and factors associated with treatment cessation.
We conducted a cohort study of antidepressant initiators in the Australian veteran population. Patients included were those who had filled at least one prescription for an antidepressant between 2005 and 2008 but had no antidepressants in the preceding 12 months. Kaplan-Meier was used to assess the treatment duration and Cox regression estimated the hazard ratio (HR) of ceasing antidepressant therapy.
There were 91,183 antidepressant users of which more than 50% were prevalent users. Among new users (n = 28,585), 50% discontinued within 6 months, and 61% within 12 months. The median duration for antidepressant treatment was 175 days [95% confidence interval (CI), 168–180]. Patients who received psychological or psychiatrist care around the time of initiation had higher persistence (HR: 0.86, CI: 0.77–0.95 and HR: 0.67, CI: 0.61–0.75 respectively), those with psychiatric disorders and dementia were also more persistent (HR: 0.82, CI: 0.77–0.88 and HR: 0.77, CI: 0.72–0.83 respectively). In contrast, patients with cancer and multi-morbidities had a higher risk of discontinuation (HR: 1.10, CI: 1.03–1.18 and HR: 1.16, CI: 1.05–1.28 respectively).
This analysis indicates persistence with antidepressants in the Australian veteran patients is inconsistent with clinical guidelines, with the majority of initiating patients provided with insufficient duration. Enhanced management of patients with characteristics associated with shorter persistence, including cancer and multi-morbidities, may improve antidepressant use.
KeywordsPersistence Determinants Antidepressant Mental health
The authors thank the Australian Department of Veterans’ Affairs for providing the data used in this study.
Dr C. Lu was supported by an Australian National Health and Medical Research Council Public Health Training Fellowship. Dr E Roughead was supported by an Australian Research Council Future Fellowship. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.
Location of work
This work was conducted at the Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute, University of South Australia.
Conflict of interest
Description of authors’ roles
Christine Lu (C.L.) and Elizabeth Roughead (E.R.) designed the study; C.L. conducted the analyses; C.L. and E.R. contributed to the interpretation of the data; C.L. drafted and reviewed the manuscript; E.R. reviewed the manuscript. All authors read and approved the final manuscript.
- 2.Australian Bureau of Statistics (2008) National Survey of Mental Health and Wellbeing: summary of results. http://www.abs.gov.au. Accessed 18 October 2010
- 5.UK National Institute for Health and Clinical Excellence (2009) Depression in adults with a chronic physical health problem: treatment and management (clinical guideline 91). NIHCE, LondonGoogle Scholar
- 6.UK National Institute for Health and Clinical Excellence (2009) Depression: the treatment and management of depression in adults (clinical guideline 90). NIHCE, LondonGoogle Scholar
- 11.World Health Organization Collaborating Centre for Drug Statistics Methodology (2010) International language for drug utilization research. Available from: www.whocc.no/. Accessed Feb 01, 2010
- 12.Australian Government Department of Health and Ageing (2009) Schedule of pharmaceutical benefits. http://www.pbs.gov.au/. Accessed Feb 01, 2010
- 13.Australian Government Department of Health and Ageing (2009) Medicare benefits schedule. http://www.health.gov.au/internet/mbsonline/publishing.nsf/Content/Medicare-Benefits-Schedule-MBS-1. Accessed Feb 01, 2010
- 14.Australian Government Department of Veterans' Affairs (2008) Australian veterans and war widows. Your lives, your needs, 5th ed. DVA, CanberraGoogle Scholar
- 15.Australian Government Department of Veterans' Affairs (2010) Treatment population statistics. Quarterly report—June 2010. http://www.dva.gov.au/aboutDVA/Statistics/Pages/Statistics.aspx#treat. Accessed May 03, 2011
- 18.Australian Bureau of Statistics (2008) SEIFA: socio-economic indexes for areas 2006. http://www.abs.gov.au. Accessed Aug 18, 2010
- 27.UK National Institute for Health and Clinical Excellence (2007) Management of anxiety (panic disorder, with or without agoraphobia and generalised anxiety disorder) in adults in primary, secondary and community care (clinical guideline 22 amended). NIHCE, LondonGoogle Scholar